| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 41,400 | 46,200 | 19:04 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | COCHLEAR LIMITED: Appointment of Prof. Ian Meredith to the Cochlear Board | 3 | ASX | ||
| Do | COCHLEAR LIMITED: Change in substantial holding | 1 | ASX | ||
| Mi | Cochlear share price rebounds 53% from 10-year low: Can it keep climbing? | 4 | The Motley Fool Australia | ||
| Mi | Cochlear vs Pro Medicus: Which beaten-down ASX healthcare share is the better buy today? | 2 | The Motley Fool Australia | ||
| 07.09. | COCHLEAR LIMITED: Change in substantial holding | 1 | ASX | ||
| 07.09. | COCHLEAR LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| COCHLEAR LIMITED ADR Aktie jetzt für 0€ handeln | |||||
| 04.09. | COCHLEAR LIMITED: Ceasing to be a substantial holder | 1 | ASX | ||
| 04.09. | COCHLEAR LIMITED: Ceasing to be a substantial holder | 18 | ASX | ||
| 03.09. | COCHLEAR LIMITED: Change in substantial holding | 1 | ASX | ||
| 03.09. | COCHLEAR LIMITED: Becoming a substantial holder | 2 | ASX | ||
| 02.09. | COCHLEAR LIMITED: Change in substantial holding | 5 | ASX | ||
| 28.08. | COCHLEAR LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 28.08. | COCHLEAR LIMITED: Update - Notification of buy-back - COH | - | ASX | ||
| 27.08. | COCHLEAR LIMITED: Becoming a substantial holder | - | ASX | ||
| 27.08. | COCHLEAR LIMITED: Appendix 3Y - Michael del Prado | 1 | ASX | ||
| 27.08. | COCHLEAR LIMITED: Appendix 3Y - Caroline Clarke | 2 | ASX | ||
| 26.08. | COCHLEAR LIMITED: Change in substantial holding | 1 | ASX | ||
| 26.08. | COCHLEAR LIMITED: Change in substantial holding | - | ASX | ||
| 25.08. | COCHLEAR LIMITED: Appendix 3Y - Michael Daniell | 1 | ASX | ||
| 25.08. | COCHLEAR LIMITED: Appendix 3Y - Alison Deans | 1 | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 45,100 | -0,42 % | Fresenius-Aktie: Score 4 - Der Patient in der Genesung - Warren Wise Podcast | Genesung ist noch keine Kerngesundheit. Fresenius meldet das beste Jahr seit Langem. Der Gewinn hat sich mehr als verdoppelt, die Schulden sind gesunken, und die Dividende ist zurück. Der Vorstand erklärt... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,850 | -0,79 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,970 | -1,69 % | EQS-News: CPT GmbH: Warren Wise scannt Siemens Healthineers: Scharfe Bilder für Ärzte, unscharfe für Investoren | EQS-News: CPT GmbH
/ Schlagwort(e): Research Update/Jahresbericht
Warren Wise scannt Siemens Healthineers: Scharfe Bilder für Ärzte, unscharfe für Investoren
18.09.2026... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 29,080 | +1,52 % | Aktien KW 38 Warsh konnte nicht bremsen. Iran verhindert mehr. TACO gefragt! News. Rheinmetall. Mutares. Verbio. Lufthansa. Hapag Lloyd. Carl Zeiss MediTec. Verbio. BASF. DEFAMA. Vonovia. Aroundtown. SFC Energy. Dürr. Evonik. Continental. Elmos Semiconduc | Aktien - es gab eine Leitzinserhöhung in den USA. Da von allen erwartet konnten die Aktienmärkte damit relativ gut umgehen. Selbst Gold und Silber atmeten einmal kurz ein udn setzten danach zum neuen... ► Artikel lesen | |
| ECKERT & ZIEGLER | 12,360 | -0,90 % | ALARMSTUFE ROT bei Eckert&Ziegler: 0,7% Minus - droht jetzt der ABSTURZ? | ||
| INTUITIVE SURGICAL | 347,55 | +1,52 % | Can AI Keep ISRG Ahead of Rising Robotic Surgery Competition? | ||
| MEDTRONIC | 79,90 | -0,40 % | Medtronic plc: Medtronic announces FDA clearance for LigaSure RAS Maryland instrument on the Hugo RAS system | Trusted vessel-sealing technology used in more than 45 million procedures worldwide is now cleared for robotic-assisted surgery in the U.S. GALWAY, Ireland, Sept. 16, 2026 /PRNewswire/... ► Artikel lesen | |
| TELADOC HEALTH | 5,450 | -0,55 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| STRAUMANN | 102,25 | +2,10 % | wO Heimspiel: Strahlend weiß: Dieser Hidden Champion glänzt mit 35% Marktanteil | © Foto: stefania - Zoonar.com/stefaniaStraumann kennt kaum einer, dabei ist der Dentalkonzern Marktführer im Implantatgeschäft. Berenberg empfiehlt die Aktie mit 118 Franken Kursziel zum Kauf. Warum... ► Artikel lesen | |
| DEXCOM | 77,40 | -0,51 % | Dexcom's CFO Jereme Sylvain To Take Addl. Role Of COO | WASHINGTON (dpa-AFX) - DexCom Inc. (DXCM), a medical device company, announced the promotion of Jereme Sylvain to the role of Chief Operating Officer in addition to his duties as Chief Financial... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 129,40 | +0,70 % | Align Technology Stock: Is ALGN Underperforming the Healthcare Sector? | ||
| HENRY SCHEIN | 74,00 | 0,00 % | Henry Schein Inc. Profit Advances In Q2 | MELVILLE (dpa-AFX) - Henry Schein Inc. (HSIC) announced earnings for its second quarter that Increases, from last yearThe company's bottom line totaled $94 million, or $0.82 per share. This... ► Artikel lesen | |
| TANDEM DIABETES | 14,900 | +1,36 % | Tandem Diabetes Care, Inc.: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets | Compatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company... ► Artikel lesen | |
| INSULET | 121,35 | -0,90 % | Insulet Corp. Q2 Profit Advances | WASHINGTON (dpa-AFX) - Insulet Corp. (PODD) released earnings for its second quarter that Increases, from the same period last yearThe company's earnings totaled $95.0 million, or $1.37 per... ► Artikel lesen | |
| AMBU | 8,705 | -1,02 % | Ambu A/S: Interim Report For Q3 | 25.8.2026 18:01:05 CEST | Ambu A/S |
Interim report (Q1 and Q3)
In Q3 2025/26, Ambu delivered organic revenue growth of 10.3%, driven by strong performance in Endoscopy Solutions growing 16.0% organically.... ► Artikel lesen |